GTR 105657383

Bids Are Invited For Acquisition Of Materials And Medicines For The Benefit Of The Oncology Pharmacy Of The Hospital De Geral De Santa Maria (Hgesm), In Accordance With The Conditions And Requirements Established In The Notice And Its Annexes.

ICB — International Competitive Bid Closed South America
Tender Information
GTR Reference
105657383
Tendering Authority
Subscribe to view
Tender No
90017/2025
Financer Name
Self-Funded
Work Title
Bids Are Invited For Acquisition Of Materials And Medicines For The Benefit Of The Oncology Pharmacy Of The Hospital De Geral De Santa Maria (Hgesm), In Accordance With The Conditions And Requirements Established In The Notice And Its Annexes.
Bid Type
ICB — International Competitive Bid
Country
Subscribe to view
Geographical Region
South America
Political Region
BRIC,G20
Last Date of Bid Submission
15-12-2025 Closed
Work Detail
Acquisition Of Materials And Medicines For The Benefit Of The Oncology Pharmacy Of The Hospital De Geral De Santa Maria (Hgesm), In Accordance With The Conditions And Requirements Established In The Notice And Its Annexes.. Abemaciclib,Abemaciclib,Acalabrutinib,Abiraterone Acetate,Anastrozole,Bicalutamide,Carboplatin,Carboplatin,Carboplatin,Cisplatin,Dabrafenib,Dabrafenib,Daratumumab,Denosumab,Docetaxel,Docetaxel,Doxorubicin Hydrochloride, Durvalumab, Durvalumab, Eltrombopag Olamine, Eltrombopag Olamine, Eribulin Mesylate, Exemestane, Calcium Folinate, Calcium Folinate, Fosaprepitant Dimeglumine, Fulvestrant, Goserelin Acetate, Goserelin Acetate, Hydroxyurea, Imatinib Mesylate,Infliximab,Lenalidomide,Lenalidomide,Letrozole,Mercaptopurine,Pembrolizumab,Pertuzumab,Regorafenib,Ribociclib,Rituximab,Rituximab,Rituximab,Ruxolitinib,Ruxolitinib,Ruxolitinib,Ruxolitinib,Tamoxifen Citrate,Trametinib,Trametinib,Trastuzumab,Trastuzumab,Trifluridine,Trifluridine,Portable Infusion Pump,Portable Infusion Pump,Portable Infusion Pump,Portable Infusion Pump,Bevacizumab,Bevacizumab,Atezolizumab,Atezolizumab,Epoetin Alfa,Anagrelide Hydrochloride,Apalutamide,Axitinib,Axitinib,Azacitidine,Bendamustine,Bleomycin Sulfate,Brentuximab Vedotin,Cabazitaxel,Capecitabine,Carfilzomib,Cyclophosphamide,Cyclophosphamide,Chlorambucil,Dasatinib,Dasatinib,Degarelix,Degarelix,Doxorubicin Hydrochloride, Etoposide, Everolimus, Gemcitabine Hydrochloride, Gemcitabine Hydrochloride, Ibrutinib, Ipilimumab, Irinotecan Hydrochloride, Irinotecan Hydrochloride,Lenvatinib,Lenvatinib,Lipegfilgrastim,Methotrexate,Nivolumab,Nivolumab,Niraparib,Olaparib,Osimertinib,Oxaliplatin
Key Value
Tender Value
Ref. Document
Tender Documents
Global Tender Document
ad4849fc-bac2-44cf-8d4e-b32f5c5f7b61.html
Attachments
Additional Details Available on Click
  • Tendering Authority
  • Publication Document (Tender Document / Tender Notice)
Disclaimer

We take all possible care for accurate & authentic tender information. However, users are requested to refer to the original Tender Notice / Tender Document published by the Tender Issuing Agency before taking any decision regarding this tender.

Tell us about your Product / Services,

We will Find Tenders for you

TenderDetail
Loading tenders